Sada KE, Kaname S, Higuchi T, Furuta S, Nagasaka K, Nanki T, Tsuboi N, Amano K, Dobashi H, Hiromura K, et al. Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody-associated vasculitis. Modern rheumatology / the Japan Rheumatism Association. 2023
Ishiguro N, Tanaka Y, Matsubara T, Atsumi T, Amano K, Sugiyama E, Yamaoka K, Winthrop K, Kivitz A, Burmester GR, et al. Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years. Modern rheumatology / the Japan Rheumatism Association. 2023. 33. 1. 64-72
Yoshinari M, Nishibata Y, Masuda S, Nakazawa D, Tomaru U, Arimura Y, Amano K, Yuzawa Y, Sada K-E, Atsumi T, et al. Low disease activity of microscopic polyangiitis in patients with anti-myosin light chain 6 antibody that disrupts active rearrangement necessary for neutrophil extracellular trap formation. Arthritis Research and Therapy. 2022. 24. 1
Nagasaka K, Amano K, Dobashi H, Nagafuchi H, Sada K-E, Komagata Y, Yamamura M, Kato M, Endo T, Nakaya I, et al. Nation-wide Cohort Study of Remission Induction Therapy using Rituximab in Japanese patients with ANCA-Associated Vasculitis: effectiveness and safety in the first six months. Modern rheumatology / the Japan Rheumatism Association. 2022
